ChatGPT for Clinicians Goes Free for U.S. Clinicians

The U.S. healthcare system is under strain as clinicians face growing administrative burdens and expanding medical research. Many are turning to AI tools like ChatGPT, with physician adoption nearly doubling to 72% over the past year. OpenAI's response is a dedicated product that integrates clinical workflows and complies with healthcare requirements, building on the earlier ChatGPT for Healthcare offering for organizations.

OpenAI emphasizes safety and accuracy, citing that physician advisors reviewed over 700,000 model responses and tested 6,924 conversations before release. In those tests, physicians rated 99.6% of responses as safe and accurate. The company also introduced HealthBench Professional, an open benchmark to evaluate model performance on real clinician chat tasks.

The stakes are high for OpenAI and the healthcare sector. While ChatGPT for Clinicians is designed to support—not replace—clinical judgment, its success likely hinges on continued physician trust and demonstrated safety. The coming expansion to non-U.S. clinicians and the ongoing refinement of model performance will be key to realizing AI's potential in health.